Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line

Jacob Bornstein, Shlomi Sagi, Amer Haj, Jeffrey Harroch, Fuad Fares

Research output: Contribution to journalArticlepeer-review


Objective. To determine whether Arsenic Trioxide may be an effective treatment of human ovarian carcinoma, we examined if it induced apoptosis in human ovarian cancer cell line. Methods. The human ovarian cell line SKOV3 was exposed to different concentrations of As2O3: 0 (control), 0.1 μM, 1 μM, 5 μM and 10 μM. The effect on cells proliferation and apoptotic parameters was examined. Results. The most effective inhibitory Arsenic Trioxide concentrations were 5 μM and 10 μM, causing growth inhibition of 79% and 83%, respectively. The maximum inhibitory effect of Arsenic Trioxide on cellular proliferation was seen after 48 h. No morphological or molecular features of apoptosis have been observed. At the same time, there were no typical changes of cellular necrosis. Conclusions. The exact mechanism by which Arsenic Trioxide inhibits the growth of ovarian cancer cells is probably not by apoptosis. However, since As2O3 has been shown to inhibit ovarian cancer cellular growth, it should be further elucidated as a possible chemotherapeutic agent of ovarian cancer.

Original languageEnglish
Pages (from-to)726-729
Number of pages4
JournalGynecologic Oncology
Issue number3
StatePublished - Dec 2005
Externally publishedYes


  • Chemotherapy
  • Cytotoxic agent
  • Female
  • Human neoplasms

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology


Dive into the research topics of 'Arsenic Trioxide inhibits the growth of human ovarian carcinoma cell line'. Together they form a unique fingerprint.

Cite this